Market View: Sea’s 400% Surge, Yangzijiang’s Big Sale, and StarHub’s Broadband Bet
Sea Limited stuns with a 400% earnings surge — is Shopee’s dominance and Monee’s rapid growth setting up more gains ahead? Hosted by Michelle Martin with Ryan Huang, this episode unpacks the drivers b...
13 Aug 202527min
Money and Me: Which of the 3 Singapore Banks is a future thriver?
Three banks, three sets of earnings — but only one clear standout. DBS defied expectations with stronger Q2 profits, while UOB and OCBC faced headwinds. Hosted by Michelle Martin, this episode with Ti...
12 Aug 202526min
Market View: Telecom Shake-Up, Trump’s Intel Reversal & Lithium’s Surge
A 90-day US-China trade truce lifts Asia-Pacific markets, but the bigger buzz is in Singapore’s telecom scene as Keppel sells M1 — to an unexpected buyer. Hosted by Michelle Martin with Ryan Huang, th...
12 Aug 202522min
Money and Me: Investors, Are You Riding on Southeast Asia’s Deal-Making Boom?
Chinese companies are eyeing the region to expand their markets amid this trade war. Today on Money and Me, Michelle Martin takes you to a story quietly gathering momentum — one that could redefine As...
11 Aug 202522min
Market View: Goldman’s Diverse Stock Picks, US Valuations, and Hyflux Trial
Will Shake Shack serve up more gains or get grilled by the market? Hosted by Michelle Martin with Ryan Huang, today’s Market View takes you inside Goldman Sachs’ latest “buy” list, featuring Shake Sha...
11 Aug 202524min
Money and Me: : From 99-1 Crackdowns to Prime & Plus Restrictions – Time to relook your property playbook?
Tighter rules are reshaping the property game in Singapore. From the High Court ruling that 99-1 ownership splits can be deemed tax evasion, to the Housing Development Board’s new Prime and Plus flat ...
8 Aug 202519min
Market View: Trump Targets Intel CEO, Genting’s Profit Slide, and a Lunar Power Play
A geopolitical jolt, corporate earnings swings, and a moonshot in energy — this Market View has it all. US President Donald Trump is calling for Intel CEO Lip-Bu Tan’s resignation, stoking US-China te...
8 Aug 202526min
Money and Me: Pharma Tariffs, AI Divergence & Palantir’s Billion-Dollar Momentum
Will your favourite pharma players suffer greatly because of Trumps' proposed massive pharma tariffs? Will embodied AI bring China ahead in the AI race vs the West? Can Palantir's monster results cont...
7 Aug 202524min
